This is a randomized, unblinded, single-centre study. After eventual surgical debridement
(not amputation), patients will be randomized to receive 1 of 2 targeted antibiotic regimens,
in the ratio 1:1.
For diabetic toe osteomyelitis, the patients will be randomized between a 3 and a 6 week's
arm, for soft tissue infections between 10 and 20 days. The final assessments used in the
primary efficacy analysis will be obtained at the test-of-cure (TOC) visit approximately 60
days after treatment is stopped.